You are here

  • Home
  • Archive
  • Volume 4, Issue 8
  • A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial)

Article metrics

Article menu

Download PDFPDF

XML
Infectious diseases
Protocol
A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial)

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201870643
Feb 201824203
Mar 201831284
Apr 20181681562
May 201894826
Jun 201884543
Jul 2018585216
Aug 201878643
Sep 201868647
Oct 2018100949
Nov 20181541468
Dec 201859594
Jan 201986786
Feb 201957515
Mar 201937299
Apr 201922203
May 201941286
Jun 201922184
Jul 201932227
Aug 201931293
Oct 201925253
Nov 201923232
Dec 2019232311
Jan 202011115
Feb 202022226
Mar 202030296
May 202028285
Jun 2020872
Jul 202017175
Aug 202032263
Sep 202024223
Oct 202034348
Nov 202029234
Dec 2020161510
Jan 202124222
Feb 20211194
Mar 202124244
Apr 202122233
May 202111102
Jun 202119194
Jul 202116164
Aug 2021996
Sep 202120199
Oct 2021171720
Nov 20218616
Dec 202119198
Jan 202224228
Feb 202214153
Mar 202248498
Apr 202219154
May 2022352511
Jun 202225226
Jul 202251512
Aug 202239354
Sep 202216149
Oct 202222186
Nov 202214147
Dec 202215150
Jan 202319163
Feb 2023242214
Mar 202324235
Apr 202319213
May 202320219
Jun 202320204
Jul 202343427
Aug 202348473
Sep 202341437
Oct 202339378
Nov 2023725821
Dec 2023323317
Jan 2024282817
Feb 202420206
Mar 2024696913
Apr 2024231210
Total27012463481